Concepedia
Statistics
Publications
8
Citations
847
H-Index
Active since
2011
Affiliations
University of Basel(Current)
University Hospital of Basel
University Medical Center Freiburg
Matthias Kreuzaler is an author at University of Basel specializing in immunology, life sciences, and immunoregulation.
Publications per year
2011–2019
Trastuzumab emtansine (T-DM1) renders HER2 <sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade
Philipp Müller, Matthias Kreuzaler, Tarik A. Khan et al. · Science Translational Medicine · 2015 · 335 citations
Medicine, Oncology, Pharmacology +17
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
Matthias Kreuzaler, Melanie Rauch, Ulrich Salzer et al. · The Journal of Immunology · 2011 · 183 citations
Life Sciences, Immunology, Pathology +17
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
Abhishek S. Kashyap, Martina Schmittnaegel, Nicolò Rigamonti et al. · Proceedings of the National Academy of Sciences · 2019 · 89 citations · Full text
Medicine, Immunology, Oncology +17
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
Sandra M. Kallert, Stéphanie Darbre, Weldy V. Bonilla et al. · Nature Communications · 2017 · 83 citations · Full text
In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development
Panagiotis Tsapogas, Lee Kim Swee, Anja Nusser et al. · Haematologica · 2014 · 69 citations · Full text
Life Sciences, Developmental Biology, Hematology +17
1–5 of 8